Abstract.
It has now been more than ten years since the discovery of the major apoptotic nuclease, DNA fragmentation factor (DFF), also known as caspaseactivated DNase (CAD). Here we review the recent literature that has uncovered new insight into DFF’s regulation, and both its positive and negative roles in human disease. Cells from mice deficient in DFF still undergo apoptotic death without significant cellautonomous DNA degradation. Their corpses’ genomes are subsequently degraded by lysosomal DNase II after phagocytosis. However,DFF-deficient mice are more susceptible to cancer. Indeed, several different cancers in humans are associated with defects in DFF expression and it has been proposed that DFF is a p53-independent tumor suppressor. Negative aspects of DFF expression include contributing to susceptibility to acquire systemic lupus erythematosus, to chromosomal translocations that result in mixed lineage leukemias, and in the possible spreading of oncogenes and HIV due to horizontal gene transfer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 06 August 2008; received after revision 03 September 2008; accepted 09 September 2008
Rights and permissions
About this article
Cite this article
Widlak, P., Garrard, W.T. Roles of the Major Apoptotic Nuclease-DNA Fragmentation Factor-in Biology and Disease. Cell. Mol. Life Sci. 66, 263–274 (2009). https://doi.org/10.1007/s00018-008-8472-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-008-8472-9